Obermatt

Flags

Financial distress

Medicover

STO:MCOV B · SE0009778848
Health Care Providers & ServicesLarge

360

21
EV / EBIT39
Price / Owner Earnings7
Owner Earnings Yield38
Dividend Yield61
Price/Sales64
EV / Gross Profit31
Price/Book23
Return on Capital68
Cash Return on Capital37
Return on Equity76
EBIT Margin57
Gross Profitability37
Cash Conversion79
Accruals19
Owner Earnings Margin37
Sales growth85
Profit Growth65
Long-Term EPS Growth88
Owner Earnings Growth67
Reinvestment34
Price momentum39
Debt load9
Refinancing41
Debt Payback7
Liquidity39
Analyst ratings61
Opinion Changes50
Price Target Upside56
Market mood93
Value Creation14/20strong value creator
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

Medicover generates returns well above its cost of capital, the foundation of durable shareholder value.

Profile

CountryCyprus
IndustryHealth Care Providers & Services
SizeLarge
TypePublic Company
ExchangeOM
Founded2016
Employees1,779
ISINSE0009778848
Last UpdateApr 2, 2026
Index & Theme
HematologyGeneticsOutpatient CareImmunologyHealth DiagnosticsInfectious DiseasesAllergyDentistryHospital

Description

Medicover AB (publ) provides healthcare and diagnostic services. Business Segments The company operates through two segments: Healthcare Services and Diagnostic Services. Healthcare Services This segment encompasses a wide range of medical servic…

Analysis

Middle-of-the-road

Medicover AB (publ) sits in the middle of our grid: average quality, average price, no obvious signal in either direction.

On valuation, the picture is expensive. The owner-earnings multiple stands at 111.2×; owner earnings: the cash an owner could take out each year. The implied growth embedded in that price is around 30% a year, against analyst forecasts of 72%. The price, in other words, assumes less than the experts do.

Growth is moderate; the safety picture is stretched. The company scores 14/20 on our value-creation score: strong value creator.

No flags apply to this company at this time: accounts, balance sheet, and cash quality all pass. A clean bill of health is meaningful, not just the absence of a warning. This analysis describes numbers; it is not investment advice.

360° rank · history

1007550250
78
2023202420252026

All-time high

78

Jun 2026

All-time low

39

Jan 2025

Average rank

52

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
64
75
73
64
Price/Earnings
16
17
10
13
Price/Book
23
16
22
18
Dividend Yield
61
45
47
48
Value (overall)
41
34
28
29

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Medicover with its peers
CVS Group
LSE:CVSG
79
CountryUK
IndustryHealth Care Providers & Services
SizeMedium
Full Stock Analysis →
Steris
NYQ:STE
63
CountryIreland
IndustryHealth Care Equipment & Supplies
SizeX-Large
Full Stock Analysis →
Spire
LSE:SPI
38
CountryUK
IndustryHealth Care Providers & Services
SizeLarge
Full Stock Analysis →
SOPHiA GENETICS
NSQ:SOPH
52
CountrySwitzerland
IndustryHealth Care Technology
SizeSmall
Full Stock Analysis →
Emeis
PAR:EMEIS
15
CountryFrance
IndustryHealth Care Providers & Services
SizeLarge
Full Stock Analysis →
Siemens Healthineers
GER:SHL
17
CountryGermany
IndustryHealth Care Equipment & Supplies
SizeX-Large
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →